BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
7.49
+0.19 (2.60%)
At close: Nov 21, 2024, 4:00 PM
7.45
-0.04 (-0.53%)
After-hours: Nov 21, 2024, 5:59 PM EST
BioCryst Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 1,551 | 1,227 | 2,140 | 2,492 | 1,315 | 532 | |
| Market Cap Growth | 17.20% | -42.68% | -14.12% | 89.45% | 147.49% | -39.93% | |
| Enterprise Value | 2,064 | 1,675 | 2,435 | 2,603 | 1,253 | 548 | |
| Last Close Price | 7.49 | 5.99 | 11.48 | 13.85 | 7.45 | 3.45 | |
| PS Ratio | 3.73 | 3.70 | 7.90 | 15.86 | 73.85 | 10.88 | |
| PB Ratio | -3.36 | -2.69 | -7.26 | -23.29 | -68.29 | 13.89 | |
| P/TBV Ratio | - | - | - | - | - | 13.89 | |
| EV/Sales Ratio | 5.00 | 5.05 | 8.99 | 16.56 | 70.34 | 11.21 | |
| Debt / Equity Ratio | -1.80 | -1.86 | -2.52 | -5.55 | -14.51 | 2.21 | |
| Asset Turnover | 0.81 | 0.62 | 0.48 | 0.34 | 0.07 | 0.30 | |
| Inventory Turnover | 10.62 | 7.71 | 12.00 | 18.93 | - | - | |
| Quick Ratio | 2.62 | 2.97 | 4.50 | 5.18 | 2.92 | 1.72 | |
| Current Ratio | 2.78 | 3.31 | 4.90 | 5.46 | 3.06 | 1.78 | |
| Return on Equity (ROE) | - | - | - | - | -1925.37% | -248.94% | |
| Return on Assets (ROA) | -4.25% | -11.57% | -16.30% | -24.07% | -41.60% | -38.59% | |
| Return on Capital (ROIC) | -5.34% | -14.70% | -19.88% | -29.76% | -55.37% | -53.14% | |
| Earnings Yield | -7.98% | -18.47% | -11.55% | -7.39% | -13.90% | -20.49% | |
| FCF Yield | -3.66% | -7.93% | -7.63% | -5.80% | -10.31% | -16.92% | |
| Buyback Yield / Dilution | -8.84% | -3.38% | -3.79% | -7.08% | -44.69% | -12.03% | |
| Total Shareholder Return | -8.84% | -3.38% | -3.79% | -7.08% | -44.69% | -12.03% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.